Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial ribosome protein synthesis is the process by which bacteria translate genetic information encoded in messenger RNA (mRNA) into functional proteins. This process occurs on the bacterial ribosome, a 70S macromolecular complex composed of ribosomal RNA (rRNA) and proteins. The bacterial ribosome is a primary target for many antibiotics due to its essential role in cell viability and its structural differences from eukaryotic ribosomes. Protein synthesis can be divided into four main stages: Initiation, Elongation, Termination, and Ribosome Recycling. Many antibiotics exploit differences between prokaryotic and eukaryotic translation machinery, making it a valuable drug target.
Inhibition of bacterial protein synthesis by targeting the 30S or 50S ribosomal subunits.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Ribosomal Protein Synthesis (N/A).